GSK confirms planned changes at Scottish API plant

By Gareth Macdonald contact

- Last updated on GMT

GSK Irvine, Scotland (source Google maps)
GSK Irvine, Scotland (source Google maps)

Related tags: Pharmaceutical drug, Pharmacology, Gsk

GSK has confirmed it plans to make changes at its active pharmaceutical ingredient (API) facility in Irvine in North Ayrshire, Scotland.

The week the Scottish press​ reported that GSK plans to eliminate 55 jobs at the facility – which makes APIs for drugs like the antibiotic Augmentin.

A GSK spokesperson confirmed changes to operations are planned, but he declined to provide specific details.

GSK Irvine is vital to our medicines manufacturing network around the world, and will continue to remain so. Following a review of our work at the site, we are proposing to make some changes to the site which will potentially impact a small number of employees​.”

We have spoken with colleagues and will support those impacted by the news, consulting with them and their representatives appropriately over the coming months​,” he said.

The news comes a year after GSK said ​ it would create 55 jobs at the facility. At the time it cited growing demand for antibiotics in developing countries.

The spokesman also told us "the review of GSK Irvine and the proposed changes are not related to Brexit​."  

Related news

Show more

Related products

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more

Webinars